Otsuka Holdings
4578.T
#579
Rank
โ‚น3.785 T
Marketcap
โ‚น7,229
Share price
1.93%
Change (1 day)
48.22%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Earnings for Otsuka Holdings (4578.T)

Earnings in 2026 (TTM): โ‚น303.12 Billion

According to Otsuka Holdings 's latest financial reports the company's current earnings are โ‚น16.95 Billion. In 2025 the company made an earning of โ‚น308.60 Billion, an increase over its 2024 earnings that were of โ‚น211.71 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Otsuka Holdings from 2010 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น303.12 B-1.78%
2025 โ‚น308.60 B45.77%
2024 โ‚น211.71 B117.32%
2023 โ‚น97.42 B-20.93%
2022 โ‚น123.20 B-12.7%
2021 โ‚น141.12 B-19.92%
2020 โ‚น176.24 B13.9%
2019 โ‚น154.74 B52.07%
2018 โ‚น101.75 B11.22%
2017 โ‚น91.49 B-36.03%
2016 โ‚น143.01 B31.15%
2015 โ‚น109.04 B
2013 โ‚น226.33 B33.52%
2012 โ‚น169.51 B-4.65%
2011 โ‚น177.78 B45.53%
2010 โ‚น122.17 B